New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Immunotherapy after surgery found to provide significant, durable benefit for high-risk bladder patients

Immunotherapy after surgery found to provide significant, durable benefit for high-risk bladder patients

byThe Mount Sinai HospitalCredit: Unsplash/CC0 Public DomainImmunotherapy after surgery increased bladder cancer patients' chance of staying cancer-free compared to patients who received a p
Oncology January 04,2024
Immunotherapy after surgery found to provide significant, durable benefit for high-risk bladder patients

Immunotherapy after surgery found to provide significant, durable benefit for high-risk bladder patients

byThe Mount Sinai HospitalCredit: Unsplash/CC0 Public DomainImmunotherapy after surgery increased bladder cancer patients' chance of staying cancer-free compared to patients who received a p
Oncology January 04,2024
Outdoor air pollution may increase non-lung cancer risk in older adults

Outdoor air pollution may increase non-lung cancer risk in older adults

byHarvard T.H. Chan School of Public HealthCredit: Unsplash/CC0 Public DomainChronic exposure to fine particulate air pollutants (PM2.5) and nitrogen dioxide (NO2) may increase non-lung cancer r
Oncology January 04,2024
Outdoor air pollution may increase non-lung cancer risk in older adults

Outdoor air pollution may increase non-lung cancer risk in older adults

byHarvard T.H. Chan School of Public HealthCredit: Unsplash/CC0 Public DomainChronic exposure to fine particulate air pollutants (PM2.5) and nitrogen dioxide (NO2) may increase non-lung cancer r
Oncology January 04,2024
Moderate exercise helps colorectal cancer patients live longer by reducing inflammation and improving gut bacteria

Moderate exercise helps colorectal cancer patients live longer by reducing inflammation and improving gut bacteria

by Heather Simonsen,University of UtahCredit: Pixabay/CC0 Public DomainRegular physical activity can extend colorectal cancer patients' lives. In a first-ever study, scientists looked at the
Oncology January 04,2024
Moderate exercise helps colorectal cancer patients live longer by reducing inflammation and improving gut bacteria

Moderate exercise helps colorectal cancer patients live longer by reducing inflammation and improving gut bacteria

by Heather Simonsen,University of UtahCredit: Pixabay/CC0 Public DomainRegular physical activity can extend colorectal cancer patients' lives. In a first-ever study, scientists looked at the
Oncology January 04,2024
Video animation guide to help young people living with cancer-related fatigue

Video animation guide to help young people living with cancer-related fatigue

byUniversity of BathCredit: University of BathA new resource has been launched by a team of psychologists at the University of Bath aiming to help young people living with cancer-related fatigue
Oncology January 04,2024
Video animation guide to help young people living with cancer-related fatigue

Video animation guide to help young people living with cancer-related fatigue

byUniversity of BathCredit: University of BathA new resource has been launched by a team of psychologists at the University of Bath aiming to help young people living with cancer-related fatigue
Oncology January 04,2024
Retinol disruption and the role of vitamin A metabolism in colon cancer

Retinol disruption and the role of vitamin A metabolism in colon cancer

by Impact Journals LLCRetinol-mediated suppression of tumor-promoting IL-6 is disrupted in colon cancer-associated fibroblasts. Credit: 2023 Villéger et al.A new research perspective was published in&
Oncology January 04,2024
Retinol disruption and the role of vitamin A metabolism in colon cancer

Retinol disruption and the role of vitamin A metabolism in colon cancer

by Impact Journals LLCRetinol-mediated suppression of tumor-promoting IL-6 is disrupted in colon cancer-associated fibroblasts. Credit: 2023 Villéger et al.A new research perspective was published in&
Oncology January 04,2024
Trial shows improvements in several clinical outcomes for men with intermediate-risk prostate cancer

Trial shows improvements in several clinical outcomes for men with intermediate-risk prostate cancer

by NRG OncologyCredit: Unsplash/CC0 Public DomainResults from the phase 3 NRG Oncology RTOG 0815 clinical study comparing dose-escalated radiotherapy (RT) alone to dose-escalated RT with short-term an
Oncology January 04,2024
Trial shows improvements in several clinical outcomes for men with intermediate-risk prostate cancer

Trial shows improvements in several clinical outcomes for men with intermediate-risk prostate cancer

by NRG OncologyCredit: Unsplash/CC0 Public DomainResults from the phase 3 NRG Oncology RTOG 0815 clinical study comparing dose-escalated radiotherapy (RT) alone to dose-escalated RT with short-term an
Oncology January 04,2024
Trial shows promise for new antibody cancer treatment

Trial shows promise for new antibody cancer treatment

byKing's College LondonMechanism of cytotoxicity mediated by MOv18 IgE. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-39679-9The first ever clinical trial of a new
Oncology January 04,2024
Trial shows promise for new antibody cancer treatment

Trial shows promise for new antibody cancer treatment

byKing's College LondonMechanism of cytotoxicity mediated by MOv18 IgE. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-39679-9The first ever clinical trial of a new
Oncology January 04,2024
Trial demonstrates acute lymphoblastic leukemia treatment advance

Trial demonstrates acute lymphoblastic leukemia treatment advance

by Diane Dragaud, ECOG-ACRIN Cancer Research GroupCredit:LBA-1 Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-Lineage Acute Lymphoblas
Oncology January 04,2024
Trial demonstrates acute lymphoblastic leukemia treatment advance

Trial demonstrates acute lymphoblastic leukemia treatment advance

by Diane Dragaud, ECOG-ACRIN Cancer Research GroupCredit:LBA-1 Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-Lineage Acute Lymphoblas
Oncology January 04,2024
Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi
Oncology January 04,2024
Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi
Oncology January 04,2024
Three-drug combination therapy effective in patients with high-risk chronic lymphocytic leukemia, trial shows

Three-drug combination therapy effective in patients with high-risk chronic lymphocytic leukemia, trial shows

byDana-Farber Cancer InstituteNew research shows that genetics account for only five to 10 per cent of risk for most human diseases, and that gene testing is a poor predictor of whether someone
Oncology January 04,2024
Three-drug combination therapy effective in patients with high-risk chronic lymphocytic leukemia, trial shows

Three-drug combination therapy effective in patients with high-risk chronic lymphocytic leukemia, trial shows

byDana-Farber Cancer InstituteNew research shows that genetics account for only five to 10 per cent of risk for most human diseases, and that gene testing is a poor predictor of whether someone
Oncology January 04,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com